Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease
BACKGROUND: Although 5-aminosalicylic acid (5-ASA) preparations used to treat inflammatory bowel disease are reported to have fewer side effects than sulphasalazine, increased clinical use of these compounds has resulted in increased reports of significant side effects.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1999-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1999/361431 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549320584331264 |
|---|---|
| author | Andrew W Kirkpatrick Arthur A Bookman Flavio Habal |
| author_facet | Andrew W Kirkpatrick Arthur A Bookman Flavio Habal |
| author_sort | Andrew W Kirkpatrick |
| collection | DOAJ |
| description | BACKGROUND: Although 5-aminosalicylic acid (5-ASA) preparations used to treat inflammatory bowel disease are reported to have fewer side effects than sulphasalazine, increased clinical use of these compounds has resulted in increased reports of significant side effects. |
| format | Article |
| id | doaj-art-9a559319349a4623b544ef003f536e21 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 1999-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-9a559319349a4623b544ef003f536e212025-02-03T06:11:33ZengWileyCanadian Journal of Gastroenterology0835-79001999-01-0113215916210.1155/1999/361431Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel DiseaseAndrew W Kirkpatrick0Arthur A Bookman1Flavio Habal2Trauma Services, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, CanadaDepartment of Internal Medicine and Rheumatology, , , The Toronto Hospital, Western Division, Toronto, Ontario, CanadaDepartment of Gastroenterology, Division of Internal Medicine, The Toronto Hospital, Toronto, Ontario, CanadaBACKGROUND: Although 5-aminosalicylic acid (5-ASA) preparations used to treat inflammatory bowel disease are reported to have fewer side effects than sulphasalazine, increased clinical use of these compounds has resulted in increased reports of significant side effects.http://dx.doi.org/10.1155/1999/361431 |
| spellingShingle | Andrew W Kirkpatrick Arthur A Bookman Flavio Habal Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease Canadian Journal of Gastroenterology |
| title | Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease |
| title_full | Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease |
| title_fullStr | Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease |
| title_full_unstemmed | Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease |
| title_short | Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease |
| title_sort | lupus like syndrome caused by 5 aminosalicylic acid in patients with inflammatory bowel disease |
| url | http://dx.doi.org/10.1155/1999/361431 |
| work_keys_str_mv | AT andrewwkirkpatrick lupuslikesyndromecausedby5aminosalicylicacidinpatientswithinflammatoryboweldisease AT arthurabookman lupuslikesyndromecausedby5aminosalicylicacidinpatientswithinflammatoryboweldisease AT flaviohabal lupuslikesyndromecausedby5aminosalicylicacidinpatientswithinflammatoryboweldisease |